Profile data is unavailable for this security.
About the company
Innovotech Inc. is a Canadian biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.
- Revenue in CAD (TTM)1.23m
- Net income in CAD-364.50k
- Incorporated2006
- Employees16.00
- LocationInnovotech Inc2011 94 St NW Suite 101EDMONTON T6N 1H1CanadaCAN
- Phone+1 (780) 448-0585
- Fax+1 (780) 424-0941
- Websitehttps://innovotech.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Appili Therapeutics Inc | 827.41k | -3.82m | 3.64m | 7.00 | -- | -- | -- | 4.40 | -0.0315 | -0.0315 | 0.0068 | -0.1021 | 0.3758 | -- | 0.6463 | 118,201.40 | -173.36 | -128.44 | -- | -251.87 | -- | -- | -461.35 | -2,103.81 | -- | -3.30 | -- | -- | 147.59 | -- | 59.09 | -- | 17.59 | -- |
| Marvel Biosciences Corp | 0.00 | -2.10m | 4.48m | -- | -- | -- | -- | -- | -0.0529 | -0.0529 | 0.00 | -0.0693 | 0.00 | -- | -- | -- | -268.48 | -- | -- | -- | -- | -- | -- | -- | -- | -14.33 | -- | -- | -- | -- | 10.29 | -- | -- | -- |
| StageZero Life Sciences Ltd | -100.00bn | -100.00bn | 4.90m | 40.00 | -- | -- | -- | -- | -- | -- | -- | -0.1119 | -- | -- | -- | -- | -- | -135.76 | -- | -- | -- | -2.74 | -- | -246.92 | 0.0176 | -- | -- | -- | -25.12 | 55.93 | -52.53 | -- | -- | -- |
| Innovotech Inc | 1.23m | -364.50k | 5.27m | 16.00 | -- | 7.22 | -- | 4.29 | -0.0094 | -0.0094 | 0.0315 | 0.0187 | 1.10 | 5.81 | 5.84 | -- | -32.59 | 2.90 | -37.99 | 3.56 | 68.63 | 71.56 | -29.67 | 2.19 | 2.17 | -- | 0.1115 | -- | 5.05 | 7.42 | -15.43 | -- | 35.69 | -- |
| Principal Technologies Inc | 618.64k | -1.90m | 5.53m | -- | -- | 9.11 | -- | 8.94 | -0.0766 | -0.0766 | 0.0246 | 0.0165 | 0.5664 | -- | 2.92 | -- | -170.72 | -- | -445.11 | -- | 21.57 | -- | -301.45 | -- | -- | -31.95 | 0.0959 | -- | 25.43 | -- | 23.53 | -- | -- | -- |
| Quest PharmaTech Inc | 0.00 | 12.69m | 5.92m | 0.00 | 0.4665 | 0.2657 | 0.4665 | -- | 0.075 | 0.075 | 0.00 | 0.1318 | 0.00 | -- | -- | -- | 50.73 | 7.62 | 53.01 | 8.45 | -- | -- | -- | -- | -- | -- | 0.043 | 0.00 | -- | -- | 95.35 | -- | -- | -- |
| XORTX Therapeutics Inc | 0.00 | -2.01m | 7.17m | 3.00 | -- | 1.96 | -- | -- | -0.6792 | -0.6792 | 0.00 | 1.26 | 0.00 | -- | -- | -- | -23.54 | -35.42 | -29.36 | -40.37 | -- | -- | -- | -- | -- | -- | 0.03 | -- | -- | -- | 72.04 | -- | 7.91 | -- |
| Hemostemix Inc | 0.00 | -1.94m | 7.41m | -- | -- | -- | -- | -- | -0.0214 | -0.0214 | 0.00 | -0.0959 | 0.00 | -- | -- | -- | -705.31 | -599.98 | -- | -- | -- | -- | -- | -- | -- | -1.74 | -- | -- | -- | -- | 52.21 | -- | -- | -- |
| Rakovina Therapeutics Inc | 0.00 | -2.94m | 7.67m | -- | -- | 1.88 | -- | -- | -0.0419 | -0.0419 | 0.00 | 0.0452 | 0.00 | -- | -- | -- | -46.65 | -- | -51.51 | -- | -- | -- | -- | -- | -- | -13.01 | 0.2652 | -- | -- | -- | 6.39 | -- | -- | -- |
